Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Increase the daily dose every 2 weeks by increments of. 500 mg to a maximum recommended daily dose of 1500 mg (750 mg twice daily). For KEPPRA tablet dosing
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Adults See Table 1 for the recommended preparation and administration of KEPPRA injection for adults to achieve a dose of 500 mg, 1000 mg, or 1500 mg.
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Medscape - Seizure dosing for Keppra, Keppra XR (levetiracetam) maximum daily dose of 1500 mg (750 mg BID); ≥4 years weighing 40 kg: 500 mg
Medscape - Seizure dosing for Keppra, Keppra XR (levetiracetam) maximum daily dose of 1500 mg (750 mg BID); ≥4 years weighing 40 kg: 500 mg
Comments